ITOS - ITeos Therapeutics Inc
10.15
0.020 0.197%
Share volume: 11,006,826
Last Updated: 08-28-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$10.13
0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-10-2024 | 08-08-2024 | 11-12-2024 | 03-05-2025 | 04-28-2025 | |
| Total revenue | 0.000 | 35.000 M | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 35.000 M | 0.000 | 0.000 | 0.000 | |
| inf% | -100.00% | nan% | ||||
| Operating expenses | 47.232 M | 49.166 M | 48.626 M | 49.504 M | 40.021 M | |
| Selling general and admin | 12.703 M | 12.457 M | 12.112 M | 11.809 M | 10.982 M | |
| Research and development | 34.529 M | 36.709 M | 36.514 M | 37.695 M | 29.039 M | |
| Total expenses | 47.232 M | 49.166 M | 48.626 M | 49.504 M | 40.021 M | |
| 4.09% | -1.10% | 1.81% | -19.16% | |||
| Operating income | -47.232 M | -14.166 M | -48.798 M | -49.332 M | -40.021 M | |
| Ebit | -43.388 M | -12.684 M | -51.928 M | -43.214 M | -40.463 M | |
| Pretax income | -36.002 M | -4.867 M | -43.115 M | -36.358 M | -33.513 M | |
| -86.48% | 785.86% | -15.67% | -7.82% | |||
| Income tax | 2.214 M | 2.261 M | 2.243 M | 7.354 M | 1.100 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -38.216 M | -7.128 M | -45.358 M | -43.712 M | -34.613 M | |
| 81.35% | -536.34% | 3.63% | 20.82% |